News and Media
Save the Date
TORONTO, Oct 10 – 12, 2023 – We warmly invite you to join us at World Stroke Congress 10 – 12 October 2023 in Toronto, Canada where NoNO Inc. will present results from our latest studies. To learn more, visit worldstrokecongress.org
TORONTO, Apr 4, 2023 – NoNO is Pleased to Announce the Completion of Enrollment in both the Phase 3 FRONTIER and the Phase 3 ESCAPE-NEXT Studies.
TORONTO, Nov 22, 2022 – NoNO Inc. Announces First Patient Dosed with NoNO-42 in a First in Humans Phase 1 Study
TORONTO, Apr 07, 2021 – NoNO Inc. publishes next-gen PSD-95 inhibitors extending the therapeutic potential of PSD-95 inhibition in acute stroke.
TORONTO, Dec 06, 2020 – NoNO Inc. Announces the Start of the Global Phase 3 ESCAPE-NEXT Trial of the Peptide Nerinetide in Acute Ischemic Stroke Excluding Thrombolysis.
TORONTO, Feb 20, 2020 – NoNO Inc. reports groundbreaking results from the Phase 3 ESCAPE-NA1 Study of the Peptide, Nerinetide, in Acute Ischemic Stroke.
CBC documentary recounts the story of NoNO’s journey.
The Stroke Doc tells the story of NoNO’s journey to develop a drug for people experiencing a stroke, a small protein to help the brain hold its breath during a stroke and prevent the worst of the damage. The CBC documentary, filmed over the course of a decade by Antica Productions, is about the perseverance and amazing work of so many people who have joined NoNO’s mission.
Visit https://thestrokedoc.com to learn more.
News & Media
NoNO’s Stroke Trial Could Have Major Implications for Future Treatment (BioSpace — February 2021)
‘A pivotal moment’: Canadian-developed drug shows dramatic outcomes in reducing damage caused by strokes (The Globe and Mail — Feb 2020)
NoNO Inc. Reports Groundbreaking Results from the Phase 3 Escape-Na1 Study of the Peptide, Nerinetide, in Acute Ischemic Stroke (The Canadian Business Journal — Feb 2020)
During a stroke, every second counts. This Toronto doctor’s drug shown to buy more time for patients. (Toronto Star — Feb 2020)
The future of stroke patients may depend on the part-time job of a Canadian surgeon (Quartz — March 30 2019)
A game-changing drug for stroke patients. (Globe and Mail – Nov 2018)
The Stakes are High for an Acclaimed Cerebrovascular Surgeon Searching for a Stroke Drug. (Stroke Research – Krembil Neuro – May 2017)
Order or Canada’s Newest Appointees Include Paralympian, Supreme Court Judge, and Astrophysicist. (CBC – Dec 2016)
Ondaatja, Kaspi, Ignatieff Among 100 Order of Canada Honorees. (Globe and Mail – Dec 2016)
Stroke-styming Effects of NA-1 Drug to be Studied in B.C. (CBC – Nov 2015)
Canadian Drug Trial Could be Pivotal for Stroke Patients (Globe and Mail – Mar 2015)
NA-1 Stroke Drug A Victory for Basic Research, says UPEI Team (CBC – Mar 2015)
Stroke Drug Approved for Pilot Program with Toronto Paramedics (Globe and Mail – May 2014)
One Toronto Neurosurgeons Crusade to Develop an Effective Stroke Drug (Globe and Mail – May 2014)
Promising Canadian Stroke Drug Receives Large Research Grant (Globe and Mail – May 2014)
Stroke Drug Discovered at Toronto Western Hospital (The Toronto Star – Oct 2012)
Stroke Drug Looks Promising in Human Trial (CP24 – Oct 2012)
New Drug May Protect Brain from Stroke (CTV News – Oct 2012)
New Drug to ‘Stop stroke surgery damage’ (Britain National Health Service – Oct 2012)
Drug ‘may prevent stroke damage’ (BBC News – Oct 2012)
New Drug Lower Stroke Risk After Surgery (The Telegraph – Oct 2012)
Experimental Drug Could Mitigate Brain Damage Caused by Stroke (Globe and Mail – Mar 2012)
Drug Holds Promise as Post-Stroke Therapy: Study (CTV News – Feb 2012)
Helping Brains to Help Themselves (Globe and Mail – Apr 2011)
Doctor Offers Picks for Top Medical Stories of 2009 (CTV News Dec – 2009)
Research Could Prevent the Effects of Stroke (Globe and Mail – Sept 2009)